Results of an abbreviated phase-II study with the Akt Inhibitor MK-220
- This topic has 0 replies, 1 voice, and was last updated 9 years ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Results of an abbreviated phase-II study with the Akt Inhibitor MK-2206 in Patients with Advanced Biliary Cancer.
http://www.nature.com/srep/2015/150710/srep12122/full/srep12122.html
MK-2206 –
http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=596332
Viewing 1 post (of 1 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.